The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 231.00
Bid: 224.00
Ask: 238.00
Change: 1.00 (0.43%)
Spread: 14.00 (6.25%)
Open: 230.00
High: 231.00
Low: 230.00
Prev. Close: 230.00
ANCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

10 Jul 2013 07:00

RNS Number : 9621I
Animalcare Group PLC
10 July 2013
 



Animalcare Group plc

("Animalcare" or "the Group")

 

Pre-Close Trading Update

 

Animalcare (AIM: ANCR), a leading supplier of veterinary medicines, provides a pre-close trading statement ahead of the publication of its results for the year ended 30th June 2013.

 

Animalcare has traded in line with market expectations for the year.

 

The year has seen continued growth, with revenues 11% ahead of the previous 12 months. Latest market statistics show sales of veterinary medicines for companion animals in the UK to be flat; therefore Animalcare's growth is well ahead of the general market. This trend of growth across the Group is reflected in overall underlying earnings in line with expectations.

 

The performance of our core Licensed Veterinary Medicines group was particularly notable, with revenues up by 22% compared with the prior year. Revenues for the Companion Animal Identification group were down in the period as a result of continued competition in the market, however unit sales were slightly ahead of management expectations and revenues from related services derived from the microchip database continued to grow against the previous period. Our Animal Welfare group performed well, with revenues up during the period.

 

The new product pipeline of licensed veterinary medicines has continued to deliver. Three new products were launched in the year and a fourth received its Marketing Authorisation in June, with the launch expected in the first half of the current financial year.

 

In March, Animalcare completed its relocation to new premises in the York area smoothly with no disruption to business. The new premises offer a much improved and efficient working environment with significantly more capacity for future growth.

 

The Group remains firmly on track with its stated strategy of investing in intellectual property protected products and services that will deliver future sustainable growth, supported by Animalcare's sound cash position.

 

Full year results will be announced on Wednesday 25th September 2013.

 

 

For further information, please contact:

 

Animalcare Group plc

Tel: 01904 487 427

Iain Menneer, Chief Executive Officer

Chris Brewster, Chief Financial Officer

Panmure Gordon (Nominated Adviser and Broker)

Tel: 0113 366 3179

Joanne Lake/Peter Steel

Walbrook PR Ltd

Tel: 020 7933 8780 or animalcare@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Helen Westaway

Mob: 07841 917 679

 

 

Notes to editors

 

Animalcare is a leading veterinary sales and marketing company based in York with 55 employees including a field sales force of 15 representatives selling to all veterinary practices around the United Kingdom.

 

Animalcare has developed a range ofgeneric veterinary medicines and animal identification products primarily to companion animal veterinary markets.  

 

Animalcare operates in three product areas:

 

·; Licensed Veterinary Medicines - a range of branded veterinary licensed pharmaceuticals sold to veterinary professionals in the UK and selected markets in Northern Europe. The range can be divided into four main categories; antibacterials, anaesthetics and analgesics, Aqupharm intravenous fluids and vitamins & speciality pharmaceuticals.

 

·; Companion Animal Identification - Identichip is the pioneering microchip identification system in the UK. Animalcare also owns and operates the Anibase database; together the market leader in electronic identification for pets in the UK.

 

·; Animal Welfare - a range of products used by veterinary professionals in the diagnosis and care of their patients, for example intravenous infusion accessories, ophthalmic instruments, hygiene solutions and bandages and dressings.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFFLDAIAIIV
Date   Source Headline
12th Jul 202111:04 amRNSNotification of Major Holding
12th Jul 20217:00 amRNSExercise of options
9th Jul 20214:59 pmRNSNotification of Major Holding
9th Jul 20213:20 pmRNSNotification of Major Holding
8th Jul 20215:45 pmRNSResult of Secondary Placing
8th Jul 20214:41 pmRNSSecond Price Monitoring Extn
8th Jul 20214:35 pmRNSPrice Monitoring Extension
8th Jul 20212:06 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
8th Jul 20211:00 pmRNSProposed Secondary Placing
1st Jul 20217:00 amRNSTotal Voting Rights
21st Jun 20217:00 amRNSExercise of options
17th Jun 202110:17 amRNSDirector/PDMR Notification
10th Jun 20214:41 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20215:03 pmRNSResult of 2021 AGM
17th May 20217:00 amRNSAnnual Report 2020 and Notice of AGM
22nd Apr 20217:00 amRNSDaxocox approved by EU and UK authorities
30th Mar 20217:00 amRNSFull Year Results 2020
23rd Mar 20217:00 amRNSNotification of major holding
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20213:43 pmRNSDaxocox receives positive opinion from CVMP in EU
8th Feb 20212:46 pmRNSNotification of major holding
1st Feb 20217:00 amRNSAppointment of Nominated Advisor and Joint Broker
21st Jan 20217:00 amRNSTrading Update and Notice of Full Year Results
18th Nov 20207:00 amRNSGrant of options
29th Sep 20207:00 amRNSInterim Results H1 2020
28th Sep 20207:00 amRNSAnimalcare and Kane Biotech to target biofilms
23rd Jul 20207:00 amRNSTrading Update and Notice of Results
30th Jun 20204:00 pmRNSResult of AGM 2020
9th Jun 20203:55 pmRNS2019 Annual Report and Notice of 2020 AGM
28th May 20207:00 amRNSFull year results 2019
18th May 202011:20 amRNSNotice of Full Year 2019 Results
25th Mar 20207:00 amRNSTrading update, revised date for full year results
23rd Jan 20207:00 amRNSTrading Update & Notice of Results
17th Jan 20208:55 amRNSHoldings in Company
24th Sep 20197:00 amRNSHalf Year Results
25th Jul 20197:00 amRNSDirectorate Change
23rd Jul 20197:00 amRNSTrading Update & Notice of Results
16th Jul 201911:37 amRNSNotification of major holdings
25th Jun 20191:40 pmRNSResult of AGM
19th Jun 20193:52 pmRNSBoard change
10th Jun 20192:55 pmRNSDirector/PDMR Shareholding
22nd May 20197:00 amRNSAnnual Report and Notice of Annual General Meeting
8th May 201910:35 amRNSDividend Declaration
30th Apr 20197:00 amRNS2018 Full Year Results
21st Jan 20197:00 amRNSTrading Update and Notice of Results
30th Oct 20187:50 amRNSAdditional Listing
1st Oct 201812:45 pmRNSAdditional Listing
25th Sep 20185:36 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.